These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 12362505)
41. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591 [TBL] [Abstract][Full Text] [Related]
42. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients. Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971 [TBL] [Abstract][Full Text] [Related]
43. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
44. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements. Kamoi K; Ikarashi T Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073 [TBL] [Abstract][Full Text] [Related]
45. Amlodipine/ARB fixed-dose combinations for the treatment of hypertension: focus on amlodipine/olmesartan combination. Chrysant SG Drugs Today (Barc); 2008 Jun; 44(6):443-53. PubMed ID: 18596998 [TBL] [Abstract][Full Text] [Related]
46. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study. de Alvaro F; Hernández-Presa MA; J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766 [TBL] [Abstract][Full Text] [Related]
47. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy]. Ke YN; Huang J; Zhu JR; Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study. Park CG; Youn HJ; Chae SC; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Hong BK; Jeong JW; Park SH; Kwan J; Choi YJ; Cho SY Am J Cardiovasc Drugs; 2012 Feb; 12(1):35-47. PubMed ID: 22217192 [TBL] [Abstract][Full Text] [Related]
49. Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension. Sharma A; Bagchi A; Kinagi SB; Sharma YK; Baliga VP; Bollmall C Clin Ther; 2007 Dec; 29(12):2667-76. PubMed ID: 18201582 [TBL] [Abstract][Full Text] [Related]
50. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
51. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study. Neldam S; Edwards C; Jones R; Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia. Bashir S; Sherwani MU; Shabbir I; Batool A J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446 [TBL] [Abstract][Full Text] [Related]
53. [Amlodipine in long-term treatment of mild and moderate hypertension. A multicenter study]. Sauerbrey-Wullkopf N; Anlauf M Fortschr Med; 1995 Feb; 113(5):58-62. PubMed ID: 7721221 [TBL] [Abstract][Full Text] [Related]
54. Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies. Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P J Clin Pharm Ther; 2013 Feb; 38(1):48-55. PubMed ID: 23216584 [TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study. Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497 [TBL] [Abstract][Full Text] [Related]
56. [Effect of amlodipine on intravascular thrombocyte activity in patients with arterial hypertension and metabolic syndrome]. Medvedev IN; Gromnatskiĭ NI Klin Med (Mosk); 2005; 83(2):37-40. PubMed ID: 15803830 [TBL] [Abstract][Full Text] [Related]
57. Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study. Yildiz A; Hursit M; Celik AV; Kayacan SM; Yazici H; Akkaya V; Gürol AO; Karsidag K Clin Nephrol; 2002 Dec; 58(6):405-10. PubMed ID: 12508961 [TBL] [Abstract][Full Text] [Related]
58. [The influence of antihypertensive agents on plasmatic and vascular-thrombocytic homeostasis in metabolic syndrome]. Vengerovskiĭ AI; Idrisova EM; Bushkova EA; Mananko EI; Krasnova NM Eksp Klin Farmakol; 2008; 71(6):8-12. PubMed ID: 19140507 [TBL] [Abstract][Full Text] [Related]
59. [Metabolic disorders in elderly patients with hypertension and their correction with melatonin]. Shatilo VB; Bondarenko EV; Antoniuk-Shcheglova IA Adv Gerontol; 2012; 25(1):84-9. PubMed ID: 22708450 [TBL] [Abstract][Full Text] [Related]
60. [Applicability of fozinopril for correction of basic manifestations of metabolic syndrome in women with arterial hypertension]. Logacheva IV; Shustova EN; Morozova NI Ter Arkh; 2005; 77(3):60-4. PubMed ID: 15881102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]